Document is current
Any future updates will be listed below
-
Authors
Abdul Razak, Albiruni R.
Miller, Wilson H. Jr
Uy, Geoffrey L.
Blotner, Steven
Young, Anne-Marie
Higgins, Brian
Chen, Lin-Chi
Gore, Lia
-
Funding
Funding for this research was provided by:
F. Hoffmann-La Roche (N/A)
- License Information
-
More Information
Article History
Received: 23 September 2019
Accepted: 14 October 2019
First Online: 16 November 2019
Compliance with ethical standards
:
: All authors report support of the parent study and funding of editorial support from F. Hoffmann-La Roche. SB, A-MY, BH, and L-CC are employees of Roche. ARR has received research funding from Genentech/Roche. WHM has served as a consultant for Amgen, BMS, GSK, Merck, Novartis and Roche; has received research funding to his institution from Amgen, AstraZeneca, BMS, MedImmune, Merck, MethylGene, Novartis, Pfizer and Roche; and has received honoraria from BMS, GSK, Merck, Novartis and Roche. LG has served as a consultant for Amgen, Genentech/Roche and Novartis; has stock with Amgen, Anchiano, Blueprint Medicines, Celgene, Clovis, Mirati and Sanofi; and has a spouse employed with Anchiano.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
